Symbol="AVRO"
AssetType="Common Stock"
Name="AVROBIO Inc"
Description="AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases after a single dose worldwide. The company is headquartered in Cambridge, Massachusetts."
CIK="1681087"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="ONE KENDALL SQUARE, BLDG. 300, SUITE 201, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="64834000"
EBITDA="-99867000"
PERatio="None"
PEGRatio="None"
BookValue="1.202"
DividendPerShare="0"
DividendYield="0"
EPS="-2.29"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.49"
ReturnOnEquityTTM="-1.03"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.29"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="3.8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.355"
EVToRevenue="-"
EVToEBITDA="0.619"
Beta="1.498"
num_52WeekHigh="1.93"
num_52WeekLow="0.56"
num_50DayMovingAverage="1.07"
num_200DayMovingAverage="0.967"
SharesOutstanding="44105100"
DividendDate="None"
ExDividendDate="None"
symbol="AVRO"
open="1.49"
high="1.51"
low="1.44"
price="1.47"
volume="1089264.00"
latest_trading_day="2023-07-21"
previous_close="1.49"
change="-0.02"
change_percent="-1.3423%"
aroon_positive_momentum_days="85"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="85"
Volume_recent_avg="1984157"
Change_recent_avg="-0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-1.04"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="85"
Aroon_momentum_negative="15"
image_negative_thumbnail_id_1="137"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0039.jpeg"
image_negative_thumbnail_id_2="96"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0080.jpeg"
image_neutral_thumbnail_id_1="570"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_neutral_thumbnail_id_2="543"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0056.jpeg"
image_positive_thumbnail_id_1="671"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0037.jpeg"
image_positive_thumbnail_id_2="657"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0051.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
